UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,427.30 -11.20 (-0.46%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,679.96 -301.25 (-0.55%)
Century Therapeutics, Inc. (IPSC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 249.53M |
| Enterprise value | 103.98M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 131.90 |
| Price/book (mrq) | 1.40 |
| Enterprise value/revenue | 75.90 |
| Enterprise value/EBITDA | 0.08 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.45 |
| 52-week change 3 | -12.28% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 5.5100 |
| 52-week low 3 | 1.2800 |
| 50-day moving average 3 | 3.6581 |
| 200-day moving average 3 | 2.9464 |
Share statistics
| Avg vol (3-month) 3 | 123.51k |
| Avg vol (10-day) 3 | 81.99k |
| Shares outstanding 5 | 83.18M |
| Implied shares outstanding 6 | 82.85M |
| Float 8 | 37.04M |
| % held by insiders 1 | 28.80% |
| % held by institutions 1 | 54.67% |
| Shares short (30 Apr 2024) 4 | 1.56M |
| Short ratio (30 Apr 2024) 4 | 12.38 |
| Short % of float (30 Apr 2024) 4 | 2.31% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.88% |
| Shares short (prior month 28 Mar 2024) 4 | 1.65M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,661.87% |
Management effectiveness
| Return on assets (ttm) | -19.33% |
| Return on equity (ttm) | -58.66% |
Income statement
| Revenue (ttm) | 1.37M |
| Revenue per share (ttm) | 0.02 |
| Quarterly revenue growth (yoy) | -50.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -111.05M |
| Net income avi to common (ttm) | -133.47M |
| Diluted EPS (ttm) | -2.2200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 192.02M |
| Total cash per share (mrq) | 2.32 |
| Total debt (mrq) | 46.47M |
| Total debt/equity (mrq) | 26.12% |
| Current ratio (mrq) | 12.44 |
| Book value per share (mrq) | 2.74 |
Cash flow statement
| Operating cash flow (ttm) | -89.38M |
| Levered free cash flow (ttm) | -65.98M |
© 2024 Yahoo. All rights reserved.